BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 18423777)

  • 1. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
    Hughes ZA; Liu F; Platt BJ; Dwyer JM; Pulicicchio CM; Zhang G; Schechter LE; Rosenzweig-Lipson S; Day M
    Neuropharmacology; 2008 Jun; 54(7):1136-42. PubMed ID: 18423777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
    Jesse CR; Wilhelm EA; Bortolatto CF; Nogueira CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):294-302. PubMed ID: 19961893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
    Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
    Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
    Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
    Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
    Hirano S; Miyata S; Onodera K; Kamei J
    Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
    Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
    Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems.
    Capra JC; Cunha MP; Machado DG; Zomkowski AD; Mendes BG; Santos AR; Pizzolatti MG; Rodrigues AL
    Eur J Pharmacol; 2010 Sep; 643(2-3):232-8. PubMed ID: 20599906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system.
    Machado DG; Bettio LE; Cunha MP; Capra JC; Dalmarco JB; Pizzolatti MG; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):642-50. PubMed ID: 19286446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.
    Gay BM; Prigol M; Stein AL; Nogueira CW
    Neuropharmacology; 2010 Sep; 59(3):172-9. PubMed ID: 20488195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system.
    Machado DG; Kaster MP; Binfaré RW; Dias M; Santos AR; Pizzolatti MG; Brighente IM; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):421-8. PubMed ID: 17182164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents.
    Xu Q; Yi LT; Pan Y; Wang X; Li YC; Li JM; Wang CP; Kong LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):715-25. PubMed ID: 18093712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.